Research at the BfArM concentrates on important and contemporary research focal points with regard to the marketing authorisation of medicinal products and improving the safety thereof as well as concerning the recording and assessment of risks in connection with medical devices. These focal points are represented by different interdisciplinary research groups that co-operate closely in the development of research issues with leading national, European, and international research facilities both on university and non-university levels. As a major licensing authority in Europe, the BfArM's research also promotes the regulatory expertise of its scientific staff on an on-going basis.
The research areas pharmacogenomics and individualised pharmacotherapy are concerned with the variability of patients' drug responses that is caused by inborn genetic differences.
Pharmacoepidemiology employs methods and findings from epidemiology and applies them to issues in connection with medication safety.
The research area focusses on drug allergies, cutaneous adverse drug reactions and dedicated pharmacovigilance questions.
Safety of Medical Devices
The development of complex technical systems for diagnostic measures, therapy, and implantation coincident with short innovation cycles mark the scientific progress of medical devices.
The research area neuropsychopharmacology investigates the effects of anti-psychotic, anti-depressant, anti-dementia, and anti-epileptic drugs on the complex central rhythmicity of our central nervous system.
Scientific progress and innovative development with regard to medicinal products always entail new challenges for the prevention of health risks.
The field of biostatistics is concerned with the collection and evaluation of data in the different life sciences.